Should you take a look at these 3 shares after today’s news?

Three great shares to keep an eye on for future investment potential.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

These three companies all updated the market today and I think investors should add all three to their watch list. 

Impressive miner

Kaz Minerals (LSE: KAZ) updated the market on its production figures from the first half of the year. Copper cathode equivalent production was up 43% and the company remains on track to meet full-year 2016 production guidance of 130-155 kt. Gold production rose significantly from 16.1koz to 39.1koz year-on-year. Although gold is only a small part of the company, it’s encouraging to see Kaz taking advantage of higher gold prices. 

Today the CEO of Kaz said that we “are now delivering the highest growth rate in the sector and we look forward to updating the market on our financial performance when we announce our half-year results in August.” The market has been impressed with the results this morning and shares are up over 4.5%. If Kaz really does have the highest growth rate in the sector then those shares could go a lot higher. 

Next chapter for Melrose

Investment company Melrose Industries (LSE: MRO) released its half-yearly report today. The results had no surprises and although a small loss was made it’s nothing to worry about. I’d like to draw your attention to the new investment Melrose has made recently. The company is beginning a new chapter by purchasing Nortek for just over £2bn. This acquisition was made on the back of an incredibly successful investment in Elster that returned over £2.5bn to shareholders following its sale in December 2015.

The new purchase follows the companies strategy of “buy, improve, sell”. Melrose is hoping that the transaction will be completed in late August or early September. The shares could go much higher if the company’s new investment produces similar returns to its last. 

Pharma earnings hit

AstraZeneca (LSE: AZN) released a set of lacklustre results this morning but somewhat surprisingly, the shares are up over 2% today. Core earnings per share fell over 31% in Q2, which is slightly worrying, but the company is sticking with guidance of a low-to-mid single-digit decline in earnings and revenue in 2016. 

Analysts see Astra making another loss in 2017 before moving back to growth in 2018 as new products hit the market. The company has also been subject to further bid speculation, not from Pfizer, which made a bid for the company two years ago, but from the Swiss pharmaceuticals group Novartis. Astra’s CEO was asked to comment on whether Astra itself was looking at any acquisitions but he said “we have a really full pipeline, so we would be extremely unlikely to consider a pipeline acquisition”. Shares are up nearly 2% on the back of today’s news, despite earnings being hit. This may be due to those bid rumours but Astra remains one to watch closely over the next few months for further bid speculation. 

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Jack Dingwall has no position in any shares mentioned. The Motley Fool UK owns shares of Melrose. The Motley Fool UK has recommended AstraZeneca. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

3 ideas to help investors aim for a million-pound Stocks & Shares ISA

The UK has a growing number of Stocks and Shares ISA millionaires, and this plan may be one of the…

Read more »

Illustration of flames over a black background
Investing Articles

2 red-hot UK growth stocks to consider buying in April

These two growth stocks are performing well, but can they continue to deliver for investors through 2024 and beyond?

Read more »

Charticle

Is JD Sports Fashion one of the FTSE 100’s best value stocks? Here’s what the charts say!

The JD Sports Fashion share price remains a wild ride during the first quarter. Could it be one of the…

Read more »

Investing Articles

Could the JD Sports Fashion share price double in the next five years?

The JD Sports Fashion share price has nearly halved in the past five years. Our writer thinks a proven business…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

If interest rate cuts are coming, I think these UK growth stocks could soar!

Falling interest could be great news for UK growth stocks, especially those that have been under the cosh recently. Paul…

Read more »

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »